Mohsin Jameel CEO and founder of TradeNext, a London headquartered FCA regulated firm, is highlighting the positive aspects of OTC products at the auspicious World Exchange Congress in Doha, Qatar.
Financial instruments traded over-the-counter (OTC) have been criticised by governments and regulators for their contribution to the 2008 global recession. Claims that OTC markets are less transparent and operate with fewer rules than exchanges are being addressed with major regulatory reforms under way in the United States, European Union, and other developed financial markets, as approved at the G20 Summit in 2009.
According to UK based TradeNext, a multi asset, multi-platform provider, once implemented, OTC still has charm in the non-standardised contracts and will again become an attractive investment vehicle.
Speaking at the Congress on Wednesday 26 March, being held at the St Regis Doha, Mr Jameel, will say: "The market is constantly evolving with technology, creating new layers of supervision and surveillance that outweigh the disadvantages with OTC products. Despite the flack OTC products receive, instruments such as currencies and swaps are the most liquid in terms of notional volumes, with FX derivatives crossing the $5 trillion mark in daily trading volume, according to the BIS Triennial FX Survey 2013. OTC products give users flexibility as well as freedom to dictate conditions that accommodate the users’ needs.”
Mr Jameel adds: "One size doesn't fit all, and although exchanges have their benefits, such as price setting, rapid execution times and removing counterparty risk, OTC can offer corporates and institutions greater flexibility and lower transaction costs."
The annual event is the premier gathering of influencers and decision makers, connecting leaders from over 300 exchange as well as CTOs and Heads of Technology, representing over 50 countries.